adj rev incl zantac addback line w/con
adj ebita con driven consum upsid
offset rx downsid adj ep con
management maintain revenue guidanc
perform summari revenu line con
ebita con
ep con
note adj earn excl loss associ zantac recal
pre-tax tax
ep upsid vs model includ revenu cog sg
i/ yoy growth nutshel rev gross profit oper inc pre-tax
consum self-car america csca
gross profit gross margin
 oper incom ebita
oper margin
consum self-car csci
gross profit gross margin
 oper incom ebita
oper margin
rx gross profit
gross margin
oper incom ebita
oper margin
ep guidanc rais unchang revenu guidanc midpoint
line con ep guidanc midpoint
rais line con
 unit state america
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
per share equat approxim pre-tax
consensu thomson reuter
pt base ep target price-to-earnings discount mean
lower end standard deviat rang con ntm ep
risk achiev price
new product launch delay
new invest spend enhanc prospect higher anticip
dilut associ rx exit wors expect
neg newsflow rx price collus investig recal offic
examin fbi year ago part investig
